Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

GBS, Pertussis in Latin America

This website is archived for historical purposes and is no longer being maintained or updated.

June 13, 2013: Content on this page kept for historical reasons.

Division of Bacterial Diseases (DBD) News Bulletin

Spring 2013

Preventing GBS through Electronic Platforms

Despite more than a decade of prevention efforts, group B Streptococcus (GBS) remains the leading cause of early-onset neonatal sepsis in the US. The most recent Guidelines for Prevention of Perinatal GBS Disease were published in 2010 and were endorsed by the American College of Obstetricians and Gynecologists, American Academy of Pediatrics, American College of Nurse-Midwives, American Academy of Family Physicians, and American Society for Microbiology. The cornerstones of GBS prevention are prenatal screening of all pregnant women for GBS colonization, giving appropriate intrapartum antibiotic prophylaxis (IAP) to GBS-colonized women and to those with specific risk-factors, and appropriately managing neonates at high risk for early onset group B streptococcal (EOGBS) disease.